Essex Investment Management’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-66
Closed -$830K 515
2019
Q3
$830K Buy
+66
New +$530K 0.12% 236
2019
Q2
Sell
-40
Closed -$526K 516
2019
Q1
$526K Sell
40
-29
-42% -$493K 0.08% 259
2018
Q4
$1.04M Sell
69
-66
-49% -$1.55M 0.16% 187
2018
Q3
$5.05M Sell
135
-1
-0.7% -$32.9K 0.59% 37
2018
Q2
$5.26M Buy
136
+4
+3% +$152K 0.66% 30
2018
Q1
$4.28M Sell
132
-5
-4% -$135K 0.56% 42
2017
Q4
$2.81M Sell
137
-4
-3% -$82.6K 0.37% 75
2017
Q3
$2.97M Buy
141
+99
+236% +$1.84M 0.4% 60
2017
Q2
$668K Buy
42
+29
+223% +$581K 0.1% 235
2017
Q1
$340K Sell
13
-3
-19% -$84.4K 0.05% 293
2016
Q4
$413K Sell
16
-32
-67% -$986K 0.07% 269
2016
Q3
$1.73M Sell
48
-19
-28% -$624K 0.28% 94
2016
Q2
$2.64M Sell
67
-1
-1% -$45.1K 0.44% 57
2016
Q1
$3.36M Hold
68
0.58% 41
2015
Q4
$3.73M Buy
68
+16
+31% +$863K 0.58% 41
2015
Q3
$2.27M Buy
52
+15
+41% +$997K 0.37% 61
2015
Q2
$3.02M Buy
37
+7
+23% +$607K 0.46% 60
2015
Q1
$2.3M Sell
30
-4
-12% -$371K 0.32% 81
2014
Q4
$3.23M Buy
34
+4
+13% +$330K 0.47% 60
2014
Q3
$2.74M Buy
+30
New +$2.79M 0.42% 69

Other funds holding TTOO

Essex Investment Management's TTOO Position: Q4 2019 in Review

Essex Investment Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2019, closing a stake of 66 shares — an estimated $830K sold.

Essex Investment Management first reported a position in TTOO in Q3 2014 and held it in 20 quarters. The position peaked at $5.26M in Q2 2018. 43 funds tracked by Wall St. Rank hold TTOO as of Q4 2019.

  • Essex Investment Management reported no remaining T2 Biosystems, Inc position as of Q4 2019 after selling out during the quarter.
  • Essex Investment Management sold 66 T2 Biosystems, Inc shares in Q4 2019, an estimated $830K.
  • Essex Investment Management first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 20 quarters.
  • Essex Investment Management's T2 Biosystems, Inc position peaked at $5.26M in Q2 2018.
  • 43 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2019.

Based on Essex Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.